CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: analyzed the miRNome of the LSC-enriched CD34+CD38-CD26+ fraction in CML-CP patients and found a more than 9-fold increase in miR-196a-5p in the CD26+ (BCR-ABL1+) versus CD26- (BCR-ABL1-) CD34+CD38- fraction at diagnosis (60).